S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
S&P 500   3,855.36
DOW   30,960.00
QQQ   328.11
Log in
NASDAQ:PRTO

Proteon Therapeutics News Headlines

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range
$0.84
MA: $19.37
$25.13
52-Week Range N/A
Volume3.93 million shs
Average Volume1.11 million shs
Market Capitalization$442.47 million
P/E RatioN/A
Dividend YieldN/A
Beta0.6

Headlines

Proteon Therapeutics (NASDAQ PRTO) News Headlines Today

Source:
SourceHeadline
Proteon Therapeutics (NASDAQ:PRTO) Stock Passes Below Fifty Day Moving Average of $19.53Proteon Therapeutics (NASDAQ:PRTO) Stock Passes Below Fifty Day Moving Average of $19.53
americanbankingnews.com - January 21 at 4:34 AM
Proteon Therapeutics (NASDAQ:PRTO) Hits New 52-Week High at $25.20Proteon Therapeutics (NASDAQ:PRTO) Hits New 52-Week High at $25.20
americanbankingnews.com - January 4 at 7:46 PM
DuPont Animal Nutrition to Partner with Proteon Pharmaceuticals in the Poultry IndustryDuPont Animal Nutrition to Partner with Proteon Pharmaceuticals in the Poultry Industry
finance.yahoo.com - September 9 at 12:49 PM
Moore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina TruMoore Kuehn, PLLC Encourages Liberty Property Trust (LPT), Proteon Therapeutics (PRTO), Ra Pharmaceuticals (RARX), Carolina Tru
www.bloomberg.com - December 10 at 11:59 PM
Hedge Funds Watching Proteon Therapeutics Inc (PRTO) From AfarHedge Funds Watching Proteon Therapeutics Inc (PRTO) From Afar
finance.yahoo.com - November 30 at 12:00 AM
Moore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), andMoore Kuehn, PLLC Encourages Vitamin Shoppe, Inc. (VSI), Jagged Peak Energy Inc. (JAG), Proteon Therapeutics, Inc. (PRTO), and
www.bloomberg.com - November 24 at 6:15 AM
SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.SHAREHOLDER ALERT: WeissLaw LLP Investigates Proteon Therapeutics, Inc.
finance.yahoo.com - November 21 at 5:47 PM
Proteon Therapeutics IncProteon Therapeutics Inc
www.bloomberg.com - October 31 at 10:31 PM
BRIEF-Proteon Therapeutics Posts Q3 $1.5 MillionBRIEF-Proteon Therapeutics Posts Q3 $1.5 Million
www.msn.com - October 31 at 10:31 PM
Proteon Therapeutics Announces Third Quarter 2019 Financial ResultsProteon Therapeutics Announces Third Quarter 2019 Financial Results
finance.yahoo.com - October 31 at 5:31 PM
Merger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – DOVA, VSI, PRTOMerger Investigation Alert: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders – DOVA, VSI, PRTO
finance.yahoo.com - October 22 at 6:56 PM
SHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - PRTO, ROAN, PGNXSHAREHOLDER INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate Whether the Sale of These Companies is Fair to Shareholders - PRTO, ROAN, PGNX
finance.yahoo.com - October 18 at 1:49 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Proteon Therapeutics, Inc. (NASDAQ CM: PRTO)SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Proteon Therapeutics, Inc. (NASDAQ CM: PRTO)
finance.yahoo.com - October 18 at 8:49 AM
PROTEON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteon Therapeutics, Inc. - PRTOPROTEON INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Proteon Therapeutics, Inc. - PRTO
finance.yahoo.com - October 3 at 9:44 PM
HLND, UCFC, and TRCB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MergersHLND, UCFC, and TRCB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
finance.yahoo.com - September 26 at 3:33 PM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Proteon Therapeutics, Inc. with ArTara Therapeutics, Inc. is Fair to PRTO ShareholdersSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Proteon Therapeutics, Inc. with ArTara Therapeutics, Inc. is Fair to PRTO Shareholders
finance.yahoo.com - September 25 at 8:33 PM
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Proteon Therapeutics, Inc. (NASDAQ: PRTO) on Behalf of Proteon Shareholders and Encourages Proteon Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating the Board of Directors of Proteon Therapeutics, Inc. (NASDAQ: PRTO) on Behalf of Proteon Shareholders and Encourages Proteon Investors to Contact the Firm
finance.yahoo.com - September 25 at 3:32 PM
PRTO, ARTX Shareholder Investigation: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – PRTO, ARTXPRTO, ARTX Shareholder Investigation: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – PRTO, ARTX
finance.yahoo.com - September 24 at 5:15 PM
PROTEON THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of MergerPROTEON THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Merger
finance.yahoo.com - September 24 at 5:15 PM
BRIEF-Proteon Therapeutics And Artara Therapeutics Agree To CombineBRIEF-Proteon Therapeutics And Artara Therapeutics Agree To Combine
www.msn.com - September 23 at 8:55 PM
Proteon and ArTara to mergeProteon and ArTara to merge
seekingalpha.com - September 23 at 8:55 PM
BRIEF-Proteon Therapeutics Reports Qtrly Net Loss Per Share $0.27BRIEF-Proteon Therapeutics Reports Qtrly Net Loss Per Share $0.27
www.msn.com - August 8 at 12:20 AM
Proteon Therapeutics EPS misses by $0.14Proteon Therapeutics EPS misses by $0.14
seekingalpha.com - August 7 at 8:43 AM
Proteon Therapeutics Announces Second Quarter 2019 Financial ResultsProteon Therapeutics Announces Second Quarter 2019 Financial Results
finance.yahoo.com - August 7 at 8:43 AM
Those Who Purchased Proteon Therapeutics (NASDAQ:PRTO) Shares Three Years Ago Have A 95% Loss To Show For ItThose Who Purchased Proteon Therapeutics (NASDAQ:PRTO) Shares Three Years Ago Have A 95% Loss To Show For It
finance.yahoo.com - July 11 at 5:30 PM
Once fast-rising KC company explores sale after second drug trial failureOnce fast-rising KC company explores sale after second drug trial failure
www.bizjournals.com - April 25 at 6:25 PM
Proteon exploring sale after 2nd drug trial failureProteon exploring sale after 2nd drug trial failure
finance.yahoo.com - April 19 at 6:15 PM
Proteon to explore strategic alternatives; shares up 8% after hoursProteon to explore strategic alternatives; shares up 8% after hours
seekingalpha.com - April 15 at 6:34 PM
Proteon Therapeutics Announces Review of Potential Strategic TransactionsProteon Therapeutics Announces Review of Potential Strategic Transactions
finance.yahoo.com - April 15 at 6:34 PM
Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?
247wallst.com - March 28 at 6:28 PM
Proteons vonapanitase flunks second late-stage studyProteon's vonapanitase flunks second late-stage study
seekingalpha.com - March 28 at 9:31 AM
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous FistulasProteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
finance.yahoo.com - March 28 at 9:31 AM
Proteon files for stock offering; shares down 4% after hoursProteon files for stock offering; shares down 4% after hours
seekingalpha.com - March 15 at 9:36 AM
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial ResultsProteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 13 at 11:17 AM
Proteon Therapeutics: 4Q Earnings SnapshotProteon Therapeutics: 4Q Earnings Snapshot
finance.yahoo.com - March 13 at 11:17 AM
Proteon Therapeutics Inc.Proteon Therapeutics Inc.
www.barrons.com - March 6 at 6:40 PM
Proteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11thProteon Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 11th
finance.yahoo.com - March 4 at 6:51 PM
Proteon down 3%Proteon down 3%
seekingalpha.com - January 24 at 5:45 PM
Results supported the design of ongoing pivotal study and FDA Breakthrough Therapy designationResults supported the design of ongoing pivotal study and FDA Breakthrough Therapy designation
globenewswire.com - January 24 at 9:20 AM
Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney DiseaseProteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
finance.yahoo.com - January 24 at 9:20 AM
Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market?Does The Proteon Therapeutics, Inc. (NASDAQ:PRTO) Share Price Fall With The Market?
finance.yahoo.com - December 20 at 4:58 PM
This page was last updated on 1/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.